Terminal sterilization of VHP
Type: Forecast
Overview
Description
Terminal sterilization of VHP is expected to be the primary alternative to EtO in the future and these will provide OSEL to develop RSTs that enable a least burdensome approach for manufacturers to switch from EtO. Would significantly impede progress or prevent developing RSTs aimed at reducing the burden of biocompatibility testing for manufacturers
Est. Value
Min: $25,000
Max: $250,000
Max: $250,000
Est. Award Date
1/1/24
Source Est. Solicitation Date
1/1/24
Set Aside
Full and Open
Forecast Type
New
Forecast Source
Health and Human Services
Food and Drug Administration is forecasted to issue a new procurement for Terminal sterilization of VHP around 1/1/24 worth up to $250,000.
Agency
Source Level 1 Agency
Health and Human Services
Source Level 2 Agency
Food and Drug Administration
Contacts
Potential Bidders and Partners
Similar Active Opportunities
Additional Detail
Date Published
11/30/23